Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Yujie Ren in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Xue Han in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Yujiang Li in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Key Laboratory of TCM Syndrome and Treatment of Yingbing (Thyroid Disease) of State Administration of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Guofang Chen in
Google Scholar
PubMed
Search for other papers by Lin Jiang in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Key Laboratory of TCM Syndrome and Treatment of Yingbing (Thyroid Disease) of State Administration of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Chao Liu in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Shuhang Xu in
Google Scholar
PubMed
Introduction With the widespread application of ultrasonography in recent decades ( 1 ), the prevalence of thyroid cancer has gradually risen to the 11th and 5th ranks in all cancers and those in women, respectively ( 2 ). Papillary thyroid
Search for other papers by David T Broome in
Google Scholar
PubMed
Search for other papers by Gauri B Gadre in
Google Scholar
PubMed
Search for other papers by Ehsan Fayazzadeh in
Google Scholar
PubMed
Search for other papers by James F Bena in
Google Scholar
PubMed
Search for other papers by Christian Nasr in
Google Scholar
PubMed
Introduction Thyroid cancer is currently the third fastest rising cancer diagnosis in the United States. The National Cancer Institute indicates that there were 52,070 new cases of thyroid cancer diagnosed in 2019 and an estimated 52,890 newly
Search for other papers by Lauren E Henke in
Google Scholar
PubMed
Search for other papers by John D Pfeifer in
Google Scholar
PubMed
Search for other papers by Thomas J Baranski in
Google Scholar
PubMed
Search for other papers by Todd DeWees in
Google Scholar
PubMed
Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri, USA
Search for other papers by Perry W Grigsby in
Google Scholar
PubMed
Protection Office at Washington University School of Medicine, including retrospective chart review (protocol number 201010705) with waiver of consent. Records of 1712 patients with invasive thyroid cancer who were referred to the Department of Radiation
Radiotherapy Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland
Search for other papers by Aleksandra Kukulska in
Google Scholar
PubMed
Search for other papers by Jolanta Krajewska in
Google Scholar
PubMed
Search for other papers by Zofia Kolosza in
Google Scholar
PubMed
Search for other papers by Ewa Paliczka-Cieslik in
Google Scholar
PubMed
Search for other papers by Aleksandra Kropinska in
Google Scholar
PubMed
Search for other papers by Agnieszka Pawlaczek in
Google Scholar
PubMed
Search for other papers by Zbigniew Puch in
Google Scholar
PubMed
Search for other papers by Kornelia Ficek in
Google Scholar
PubMed
Search for other papers by Teresa Lisik in
Google Scholar
PubMed
Search for other papers by Dorota Sygula in
Google Scholar
PubMed
Search for other papers by Zbigniew Wygoda in
Google Scholar
PubMed
Search for other papers by Jozef Roskosz in
Google Scholar
PubMed
Search for other papers by Jerzy Wydmanski in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Introduction Medullary thyroid carcinoma (MTC) is a rarely diagnosed malignant neoplasm arising from C cells and constitutes only 5% of all thyroid cancers. MTC may occur as a sporadic disease or as part of hereditary multiple endocrine
Search for other papers by Line Tang Møllehave in
Google Scholar
PubMed
Search for other papers by Marie Holm Eliasen in
Google Scholar
PubMed
Search for other papers by Ieva Strēle in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Allan Linneberg in
Google Scholar
PubMed
Université Libre de Bruxelles, Bruxelles, Belgium
Search for other papers by Rodrigo Moreno-Reyes in
Google Scholar
PubMed
Search for other papers by Ludmila B Ivanova in
Google Scholar
PubMed
School of Medicine, Zagreb, Croatia
Search for other papers by Zvonko Kusić in
Google Scholar
PubMed
Search for other papers by Iris Erlund in
Google Scholar
PubMed
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Search for other papers by Endre V Nagy in
Google Scholar
PubMed
Department of Clinical Nutrition, Landspitali-National University Hospital, Reykjavik, Iceland
Search for other papers by Ingibjorg Gunnarsdottir in
Google Scholar
PubMed
Goldman School of Medicine, Ben Gurion University of the Negev, Beer Sheva, Israel
Search for other papers by Jonathan Eli Arbelle in
Google Scholar
PubMed
Search for other papers by Aaron Milton Troen in
Google Scholar
PubMed
Search for other papers by Valdis Pīrāgs in
Google Scholar
PubMed
Search for other papers by Lisbeth Dahl in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Malgorzata Trofimiuk-Müldner in
Google Scholar
PubMed
Search for other papers by João Jacome de Castro in
Google Scholar
PubMed
Search for other papers by Mafalda Marcelino in
Google Scholar
PubMed
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Search for other papers by Simona Gaberšček in
Google Scholar
PubMed
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Search for other papers by Katja Zaltel in
Google Scholar
PubMed
Universitat Autònoma de Barcelona, Barcelona, Spain
Search for other papers by Manuel Puig-Domingo in
Google Scholar
PubMed
Search for other papers by Lluis Vila in
Google Scholar
PubMed
Frölunda Specialist Hospital, Västra Frölunda, Sweden
Search for other papers by Sofia Manousou in
Google Scholar
PubMed
Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Wallenberg Centre of Molecular and Translational Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
Search for other papers by Michael Bruce Zimmermann in
Google Scholar
PubMed
Search for other papers by Karen R Mullan in
Google Scholar
PubMed
Search for other papers by Jayne Valerie Woodside in
Google Scholar
PubMed
Search for other papers by Henry Völzke in
Google Scholar
PubMed
Search for other papers by Betina Heinsbæk Thuesen in
Google Scholar
PubMed
-population, or data in 10-year age intervals. Specific diagnoses and treatments requested were: Diagnoses: Annual number of persons diagnosed with thyroid cancer (ICD-10: C73), congenital iodine-deficiency syndrome (ICD-10: E00), iodine
Search for other papers by Weidi Wang in
Google Scholar
PubMed
Search for other papers by Lingjun Kong in
Google Scholar
PubMed
Search for other papers by Hongkun Guo in
Google Scholar
PubMed
Search for other papers by Xiangjin Chen in
Google Scholar
PubMed
patients. Studies were excluded if (i) they were case reports, reviews, conference abstracts, and posters; (ii) patients with other pathologic types of thyroid carcinoma or preoperatively bilateral thyroid cancer; (iii) patients who had undergone head and
Search for other papers by Irfan Vardarli in
Google Scholar
PubMed
Search for other papers by Manuel Weber in
Google Scholar
PubMed
Search for other papers by Frank Weidemann in
Google Scholar
PubMed
Search for other papers by Dagmar Führer in
Google Scholar
PubMed
Search for other papers by Ken Herrmann in
Google Scholar
PubMed
Search for other papers by Rainer Görges in
Google Scholar
PubMed
Introduction Calcitonin (Ctn) is secreted by the C-cells of the thyroid ( 1 ) and is a valuable tumor marker in patients with medullary thyroid carcinoma (MTC) ( 2 ). Medullary thyroid cancer, originated from the C-cells ( 3 ), occurs rarely
Search for other papers by Huy Gia Vuong in
Google Scholar
PubMed
Search for other papers by Nguyen Phuoc Long in
Google Scholar
PubMed
Search for other papers by Nguyen Hoang Anh in
Google Scholar
PubMed
Search for other papers by Tran Diem Nghi in
Google Scholar
PubMed
Search for other papers by Mai Van Hieu in
Google Scholar
PubMed
Search for other papers by Le Phi Hung in
Google Scholar
PubMed
Search for other papers by Tadao Nakazawa in
Google Scholar
PubMed
Search for other papers by Ryohei Katoh in
Google Scholar
PubMed
Search for other papers by Tetsuo Kondo in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common endocrine cancer, and its incidence has been steadily increasing over the last few decades ( 1 ). There are several subtypes of thyroid carcinoma: papillary, follicular, poorly differentiated
Search for other papers by Louise Vølund Larsen in
Google Scholar
PubMed
Search for other papers by Delphine Mirebeau-Prunier in
Google Scholar
PubMed
Search for other papers by Tsuneo Imai in
Google Scholar
PubMed
Search for other papers by Cristina Alvarez-Escola in
Google Scholar
PubMed
Search for other papers by Kornelia Hasse-Lazar in
Google Scholar
PubMed
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Luciana A Castroneves in
Google Scholar
PubMed
Search for other papers by Akihiro Sakurai in
Google Scholar
PubMed
Search for other papers by Minoru Kihara in
Google Scholar
PubMed
Search for other papers by Kiyomi Horiuchi in
Google Scholar
PubMed
Réseau TenGen, Marseille, France
Search for other papers by Véronique Dorine Barbu in
Google Scholar
PubMed
Fédération d’Endocrinologie, Hospices Civils de Lyon, Université Lyon 1, France
Search for other papers by Francoise Borson-Chazot in
Google Scholar
PubMed
Service de Génétique, AP-HP, Hôpital européen Georges Pompidou, Paris, France
Université de Paris, PARCC, INSERM, Paris, France
Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Laboratoire de Biochimie et Oncologie Moléculaire, CHU Lille, Lille, France
Search for other papers by Pascal Pigny in
Google Scholar
PubMed
Laboratoire de Génétique Moléculaire, CHU Lyon, Lyon, France
Search for other papers by Stephane Pinson in
Google Scholar
PubMed
Search for other papers by Nelson Wohllk in
Google Scholar
PubMed
Search for other papers by Charis Eng in
Google Scholar
PubMed
Search for other papers by Berna Imge Aydogan in
Google Scholar
PubMed
Search for other papers by Dhananjaya Saranath in
Google Scholar
PubMed
Search for other papers by Sarka Dvorakova in
Google Scholar
PubMed
Department of Endocrinology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de Référence des Maladies Rares de l’hypophyse HYPO, Marseille, France
Search for other papers by Frederic Castinetti in
Google Scholar
PubMed
Search for other papers by Attila Patocs in
Google Scholar
PubMed
Search for other papers by Damijan Bergant in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Mariola Peczkowska in
Google Scholar
PubMed
Search for other papers by Ana O Hoff in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
Search for other papers by Trisha Dwight in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Hartmut P H Neumann in
Google Scholar
PubMed
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Shinya Uchino in
Google Scholar
PubMed
Aix Marseille Univ, APHM, INSERM, MMG, Laboratory of Molecular Biology, Hospital La Conception, Marseille, France
Search for other papers by Anne Barlier in
Google Scholar
PubMed
Search for other papers by Christian Godballe in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Jes Sloth Mathiesen in
Google Scholar
PubMed
Vasculaire, Hôpital Avicenne, Bobigny, France), respectively. L V L, C G and J S M thank the Danish Thyroid Cancer Study Group (DATHYRCA) and the Danish MEN 2 group. References 1 Donis-Keller H Dou S Chi D Carlson KM Toshima K Lairmore TC
Search for other papers by Zhenzhen Wang in
Google Scholar
PubMed
Search for other papers by Xiangying Zhu in
Google Scholar
PubMed
Search for other papers by Xiaohui Yu in
Google Scholar
PubMed
Search for other papers by Haixia Guan in
Google Scholar
PubMed
Search for other papers by Lei Zhao in
Google Scholar
PubMed
Search for other papers by Yixia Zhang in
Google Scholar
PubMed
Search for other papers by Yuge Li in
Google Scholar
PubMed
Search for other papers by Liang Sang in
Google Scholar
PubMed
Search for other papers by Yuchen Han in
Google Scholar
PubMed
Search for other papers by Yushu Li in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
). The ‘2015 American Thyroid Association (ATA) Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer’ (referred to as the ATA classification) ( 26 ) more comprehensively defines the ultrasound features and risk